Literature DB >> 29692347

Chromatin reprogramming in breast cancer.

Erin E Swinstead1, Ville Paakinaho1,2, Gordon L Hager3.   

Abstract

Reprogramming of the chromatin landscape is a critical component to the transcriptional response in breast cancer. Effects of sex hormones such as estrogens and progesterone have been well described to have a critical impact on breast cancer proliferation. However, the complex network of the chromatin landscape, enhancer regions and mode of function of steroid receptors (SRs) and other transcription factors (TFs), is an intricate web of signaling and functional processes that is still largely misunderstood at the mechanistic level. In this review, we describe what is currently known about the dynamic interplay between TFs with chromatin and the reprogramming of enhancer elements. Emphasis has been placed on characterizing the different modes of action of TFs in regulating enhancer activity, specifically, how different SRs target enhancer regions to reprogram chromatin in breast cancer cells. In addition, we discuss current techniques employed to study enhancer function at a genome-wide level. Further, we have noted recent advances in live cell imaging technology. These single-cell approaches enable the coupling of population-based assays with real-time studies to address many unsolved questions about SRs and chromatin dynamics in breast cancer.
© 2018 Society for Endocrinology.

Entities:  

Keywords:  ChIP-seq; breast cancer; chromatin; chromatin dynamics; enhancer; estrogen receptor; single molecule; steroid receptor

Mesh:

Substances:

Year:  2018        PMID: 29692347      PMCID: PMC6029727          DOI: 10.1530/ERC-18-0033

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  217 in total

1.  FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.

Authors:  D L Stenoien; K Patel; M G Mancini; M Dutertre; C L Smith; B W O'Malley; M A Mancini
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

Review 2.  Maturing of the nuclear receptor family.

Authors:  Mitchell A Lazar
Journal:  J Clin Invest       Date:  2017-04-03       Impact factor: 14.808

3.  Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.

Authors:  Francini de Mattos Lima Lin; Katia Maciel Pincerato; Carlos Eduardo Bacchi; Edmund Chada Baracat; Filomena Marino Carvalho
Journal:  J Clin Pathol       Date:  2011-10-29       Impact factor: 3.411

Review 4.  Drug Discovery and Chemical Biology of Cancer Epigenetics.

Authors:  Scott Ribich; Darren Harvey; Robert A Copeland
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

5.  A comprehensive nuclear receptor network for breast cancer cells.

Authors:  Ralf Kittler; Jie Zhou; Sujun Hua; Lijia Ma; Yuwen Liu; Elisha Pendleton; Chao Cheng; Mark Gerstein; Kevin P White
Journal:  Cell Rep       Date:  2013-01-31       Impact factor: 9.423

6.  Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes.

Authors:  Diana A Stavreva; Waltraud G Müller; Gordon L Hager; Carolyn L Smith; James G McNally
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

7.  Genome-Scale Analysis of Cell-Specific Regulatory Codes Using Nuclear Enzymes.

Authors:  Songjoon Baek; Myong-Hee Sung
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

9.  The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements.

Authors:  Stefan Schoenfelder; Mayra Furlan-Magaril; Borbala Mifsud; Filipe Tavares-Cadete; Robert Sugar; Biola-Maria Javierre; Takashi Nagano; Yulia Katsman; Moorthy Sakthidevi; Steven W Wingett; Emilia Dimitrova; Andrew Dimond; Lucas B Edelman; Sarah Elderkin; Kristina Tabbada; Elodie Darbo; Simon Andrews; Bram Herman; Andy Higgs; Emily LeProust; Cameron S Osborne; Jennifer A Mitchell; Nicholas M Luscombe; Peter Fraser
Journal:  Genome Res       Date:  2015-03-09       Impact factor: 9.043

10.  A dynamic mode of mitotic bookmarking by transcription factors.

Authors:  Sheila S Teves; Luye An; Anders S Hansen; Liangqi Xie; Xavier Darzacq; Robert Tjian
Journal:  Elife       Date:  2016-11-19       Impact factor: 8.140

View more
  7 in total

Review 1.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

2.  Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.

Authors:  Duojiao Chen; Taylor M Parker; Poornima Bhat-Nakshatri; Xiaona Chu; Yunlong Liu; Yue Wang; Harikrishna Nakshatri
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

3.  Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

Authors:  Annamaria Salvati; Viola Melone; Assunta Sellitto; Francesca Rizzo; Roberta Tarallo; Tuula A Nyman; Giorgio Giurato; Giovanni Nassa; Alessandro Weisz
Journal:  Breast Cancer Res       Date:  2022-07-18       Impact factor: 8.408

4.  SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites.

Authors:  Ville Paakinaho; Joanna K Lempiäinen; Gianluca Sigismondo; Einari A Niskanen; Marjo Malinen; Tiina Jääskeläinen; Markku Varjosalo; Jeroen Krijgsveld; Jorma J Palvimo
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

Review 5.  Emerging role of pioneer transcription factors in targeted ERα positive breast cancer.

Authors:  Honey Pavithran; Ranjith Kumavath
Journal:  Explor Target Antitumor Ther       Date:  2021-02-28

Review 6.  Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.

Authors:  Flavia Lima Costa Faldoni; Cláudia Aparecida Rainho; Silvia Regina Rogatto
Journal:  Cells       Date:  2020-05-08       Impact factor: 6.600

Review 7.  Genome-wide crosstalk between steroid receptors in breast and prostate cancers.

Authors:  Ville Paakinaho; Jorma J Palvimo
Journal:  Endocr Relat Cancer       Date:  2021-07-22       Impact factor: 5.678

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.